United States: Health Care Update & Telehealth Policy Alert

In the previous Congress, we saw a burst of policy and industry attention to telehealth as lawmakers and stakeholders alike recognized the cost, quality, and accessibility benefits of telehealth. In the first few months of the 114th Congress, we have seen the momentum for policy to address telehealth continuing, if not increasing in pace.

Congressional Progress

SGR and Telehealth: In April, Congress passed the Medicare Access and CHIP Reauthorization Act of 2015, also known as the Sustainable Growth Rate (SGR) repeal, which addressed several aspects of telehealth policy. The legislation included Merit Based Incentive payments, the use of telehealth for timely communication of test results, timely exchange of clinical information to patients and other providers, and use of remote monitoring or telehealth as a means of care coordination. It also directed the Government Accountability Office (GAO) to study and report on the use of telehealth in federal programs and in remote patient monitoring services, including:

  1. How the definition of telehealth across various federal programs and federal efforts can inform the use of telehealth in the Medicare program;
  2. Issues that can facilitate or inhibit the use of telehealth under the Medicare program;
  3. Potential implications of greater use of telehealth with respect to payment and delivery systems; and
  4. How CMS monitors payments made under the Medicare program to providers of telehealth services.

21st Century Cures Initiative: On the House side, the Energy and Commerce Committee's 21st Century Cures Initiative targets telehealth, albeit in a more limited fashion than many stakeholders would prefer. Section 3021 of the legislation includes non-binding, "sense of the senate" language requesting the cooperation of state medical boards to coordinate practitioner licensing, and directs CMS and the Medicare Payment Advisory Commission (MEDPAC) to conduct various studies and produce reports on barriers to wider telehealth use.

Many stakeholders and advocates — including the American Telemedicine Association (ATA) — had hoped that the 21st Century Cures Act would ultimately make more significant and meaningful strides toward expanding Medicare telehealth payments, resolving licensure issues, and defining telehealth clinical guidelines. However, efforts on telemedicine policy reform are ongoing outside of the 21st Century Cures Act.

Despite the omission of substantive telehealth provisions in the 21st Century Cures Act, Representative Doris Matsui (D-CA), a member of the Energy and Commerce (E&C) Bipartisan Telemedicine Member Working Group, clarified during the Subcommittee on Health's markup of the bill that the Committee's work is not finished when it comes to telehealth. The telehealth provisions in the legislation are "designed to be an on-ramp to the ongoing effort of the working group," Matsui said. Additionally, she said that the telehealth provisions included in the legislation are "not a replacement for our larger effort that will get to ways to expand Medicare reimbursement for telehealth."

We understand that there is an effort underway on the E&C Committee to develop stand-alone legislation — and that conversations and negotiations are underway and ongoing. A primary focus would be developing potential policy options that the Congressional Budget Office (CBO) could review and determine to have a budgetary saving. This is a critical component, as previous versions of telehealth legislation have been scored by CBO to have very high costs due to increased Medicare utilization — a significant complexity that needs to be overcome in order to move legislation in this Congress.

Senate Progress: Meanwhile, the Senate is proceeding with its own version of the 21st Century Cures Initiative at a more measured pace. A group of Senators — Brian Schatz (D-HI), Roger Wicker (R-MS), John Thune (R-SD), and Thad Cochran (R-MS) — have joined together to draft a telehealth bill which seeks to increase Medicare telehealth reimbursement. The group has begun work with the Congressional Budget Office (CBO) to find telehealth coverage options that will produce savings in order to reach a final bill that does not need additional pay fors. Speaking at a Senate Commerce Subcommittee on Communications, Technology, Innovation, and the Internet hearing on the issue, Schatz said that Medicare telehealth policies are "lagging significantly" and pointed to the Veterans' Health Administration (VHA) as proof that telehealth reimbursement can yield successful outcomes — the VHA's home telehealth program reduced hospital stays and decreased admissions.

Schatz's efforts build on the long track record of his colleagues on telehealth. In the 113th Congress, Senators Wicker and Cochran introduced The Telehealth Enhancement Act of 2014, a Senate companion measure to legislation introduced by Representative Greg Harper (R-MS) in the House to extend telehealth coverage for critical access and sole-community hospitals. Wicker's office has said that this bill could be incorporated into the group's work on its telemedicine bill. Senator Thune has been a supporter of telehealth for years — including sponsoring the Fostering Independence Through Technology (FITT) Act, introducing amendments to promote remote monitoring, and advocating for telehealth to be included in Medicare alternative payment models.

Finally, telemedicine and remote monitoring will be a focus of the Senate HELP Committee moving forward. Chairman Lamar Alexander (R-TN) and the HELP Committee will likely focus on Electronic Health Records (EHRs) as part of the Senate's version of the 21st Century Cures initiative. Chairman Alexander has recently said that the version of that measure that he and the Committee are developing will go "more in depth" than the House Energy and Commerce Committee to fix problems with the EHRs, built up with $30 billion in federal incentive programs. A special workgroup, which includes Sen. Alexander and HELP Ranking Member Patty Murray (D-WA), has been meeting weekly with staff from the Office of the National Coordinator for Health Information Technology (ONC) and the office of NIH Director Francis Collins to identify ways to improve EHRs.

Chronic Care Working Group: Another effort in the Senate is being led by Senators Mark Warner (D-VA) and Johnny Isakson (R-GA), who are collaborating on a bipartisan working group to explore solutions to improve Medicare outcomes for chronic care patients. As part of the effort, the senators are seeking input on how telehealth and remote monitoring could further "strengthen care coordination and effectively provide quality chronic care." Stakeholder comments are due to this working group by Monday, June 22.

Efforts within the Administration

Within the Administration, several federal agencies have tackled various aspects of telehealth in recent months.

CMS: In March, the Centers for Medicare & Medicaid Services (CMS) unveiled its newest accountable care organization (ACO) program called the "Next Generation ACO" through the CMS Innovation Center. The announcement stated that the new ACO model would have flexibility around Medicare telehealth rules, thus allowing ACOs to utilize the technology regardless of a patient's geographic location. If passed, the SGR legislation could open the door for CMS to test telehealth payment in more than just a limited number of models currently being implemented.

USDA: The U.S. Department of Agriculture (USDA) has announced $19 million in fiscal year 2015 funding for the Distance Learning and Telemedicine (DLT) grant program. DLT provides increased access to education, training and health care resources in rural areas, including financing telecommunications equipment, computer networks and advanced technologies for use by students, teachers, medical professionals and rural residents.

FDA: In February, the Food and Drug Administration (FDA) released final guidance dealing with the regulatory treatment of Medical Device Data Systems (MDDS), which are hardware or software products that transfer, store, convert formats, and display medical device data. Of note, the FDA stated it will not enforce regulations — including registration and listing, premarket review, and post market reporting — for low risk devices. While this guidance loosens restrictions on certain hardware and software, it also clarifies that "active patient monitoring" devices fall outside the scope of MDDS and are regulated separately.

FTC: The Federal Trade Commission (FTC), as part of a staff report titled "Internet of Things: Privacy & Security in a Connected World," outlined the agency's recommendations for regulating devices and products which are interconnected through the Internet and which can send and receive data. As telehealth utilizes devices and technologies which fall under the board category of Internet of Things, the report highlights the need for cyber protections and other means of securing health privacy.


Moving forward, the amount of activity taking place in just the first few months of the 114th Congress likely sets the stage for even more policy advances in telehealth. Given the amount of activity taking place, we have put together this alert to highlight current opportunities for stakeholders to consider. We are available to discuss the contents of this alert further and to answer any questions.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions